Phosphoproteomic Analysis of Feedback Networks in T cell signaling
T 细胞信号传导反馈网络的磷酸化蛋白质组学分析
基本信息
- 批准号:10132943
- 负责人:
- 金额:$ 40.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensBindingBiochemicalBiological AssayBiological ModelsBloodCaliforniaCell LineCell physiologyCellsCellular ImmunityCellular StructuresComplexComputer AnalysisDUSP22 geneDataDiseaseEquilibriumEventFeedbackFundingImmune responseImmune systemImmunologic Deficiency SyndromesImmunologyInfectionInsulin-Dependent Diabetes MellitusKnowledgeLCP2 geneLaboratoriesMalignant NeoplasmsMass Spectrum AnalysisMethodsMicrobeMicroscopyModernizationMolecularMusNR0B2 genePLC gamma1PTPN22 genePathologicPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPlayProcessProtein Tyrosine KinaseProteinsProteomicsReceptor ActivationReceptor SignalingRegulationRegulatory PathwayResearchRheumatoid ArthritisRoleSH3 DomainsSan FranciscoScaffolding ProteinSignal PathwaySignal TransductionSignaling ProteinSiteSpeedStimulusStructureSubcellular structureSystemSystemic Lupus ErythematosusT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTestingTherapeuticTherapeutic InterventionTyrosine PhosphorylationUniversitiesVirusWisconsinadaptive immune responseantigen-specific T cellsdesignexperimental studygenetic regulatory proteininnovationinsightmembermouse modelmultidisciplinarymutantneoplastic cellnew technologynovelpathogenphosphoproteomicspreferenceprotein protein interactionrecruitresponsescaffoldsrc Homology Region 2 Domain
项目摘要
Signaling networks are crucial for the orchestration of cellular functions in response to stimuli. Knowledge
of the structure of these networks provides a basis for understanding the pathological consequences of their
malfunction and offers opportunities for designing therapeutic interventions. The complexity of these networks
and the speed with which signals are transmitted in cells makes mapping them a formidable challenge. The
typical approach for elucidating the structure of cellular signaling networks involves an iterative process of
creating signaling protein disruptions, domain mutants and site-directed mutants followed by characterization
of each mutant through a battery of cellular activation assays. As a complementary approach, modern
proteomic methods using quantitative mass spectrometry can facilitate the hypothesis-driven characterization
of signaling pathways by providing a global view of cellular phosphorylation and protein-protein interactions
through a variety of activation states.
T cells play a central role in cell-mediated immunity against viruses, a variety of microbes, and cancer.
This proposal focuses on the elucidation of the molecular details of the T cell signaling pathway using these
new technologies. Lck tyrosine kinase is the central regulator of T cell activation regulated through its
phosphorylation state. Lck autophosphorylation at Tyr394 activates the kinase, whereas phosphorylation at
Tyr505 inactivates the kinase. Four phosphatases were shown previously to act on Lck Tyr394, but how each
one is recruited to Lck and whether other negative regulatory molecules are involved is not understood. The
molecular mechanism controlling the proper distribution of Lck between the T cell receptor and downstream
signaling nodes such as the SLP76 scaffolded signalosome are not well defined. In the previous funding
period, our research team discovered that downstream members of the T cell signaling pathway regulate the
phosphorylation of Lck and its substrates. We discovered that the scaffold protein SLP-76 controls both
negative and positive feedback loops in T cell receptor signaling at Lck Tyr394. We also discovered that PLCγ1
regulates differential Lck substrate phosphorylation within the TCR and the SLP-76 complex.
To gain new insights into the pathways regulating Lck activity and spatial localization, we have assembled
a multidisciplinary team to apply novel quantitative proteomic techniques, biochemical methods, and mouse
models to provide a detailed view of the network. The central question that we will address in this project is
how SLP76 and PLCγ1 set the spatial and temporal equilibrium of Lck activation resulting in appropriate T cell
response to antigen. Successful completion of the aims will clarify the identity of the regulatory proteins
employed in each feedback loop, define molecular factors controlling the cellular localization of Lck, and define
their physiological role.
信号网络对于响应刺激的细胞功能的协调至关重要。知识
这些网络的结构为理解其病理后果提供了基础。
并为设计治疗干预措施提供了机会。这些网络的复杂性
并且信号在小区中传输的速度使得映射它们成为一个艰巨的挑战。的
用于阐明蜂窝信令网络结构的典型方法包括迭代过程
产生信号蛋白破坏、结构域突变体和定点突变体,
通过一系列的细胞活化试验来检测每一个突变体。作为一种补充方法,现代
使用定量质谱的蛋白质组学方法可以促进假设驱动的表征
通过提供细胞磷酸化和蛋白质-蛋白质相互作用的全局视图,
通过各种激活状态。
T细胞在针对病毒、各种微生物和癌症的细胞介导的免疫中发挥核心作用。
该建议的重点是阐明的分子细节的T细胞信号通路使用这些
新技术Lck酪氨酸激酶是T细胞活化的中心调节因子,通过其调节T细胞活化。
磷酸化状态Lck在Tyr394处的自磷酸化激活激酶,而在Tyr394处的磷酸化激活激酶。
Tyr505使激酶失活。以前有四种磷酸酶作用于Lck Tyr394,但每种磷酸酶如何作用于Lck Tyr394?
一个被募集到Lck,是否涉及其它负调节分子尚不清楚。的
控制Lck在T细胞受体和下游之间适当分布的分子机制
诸如SLP76支架信号体的信号传导节点没有被很好地定义。在此前的融资中,
在此期间,我们的研究小组发现,T细胞信号通路的下游成员调节T细胞信号通路。
Lck及其底物的磷酸化。我们发现,支架蛋白SLP-76控制着这两种功能,
Lck Tyr394处T细胞受体信号传导的负反馈和正反馈环。我们还发现PLC γ 1
调节TCR和SLP-76复合物内的不同Lck底物磷酸化。
为了获得对调节Lck活性和空间定位的途径的新见解,我们组装了
一个多学科的团队,应用新的定量蛋白质组学技术,生物化学方法,和小鼠
模型,以提供网络的详细视图。我们在这个项目中要解决的中心问题是
SLP76和PLC γ 1如何设置Lck激活的空间和时间平衡,从而产生适当的T细胞
对抗原的反应这些目标的成功完成将阐明调控蛋白的身份
在每个反馈回路中使用,定义控制Lck细胞定位的分子因子,并定义
生理作用。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantitative phosphoproteomics reveals SLP-76 dependent regulation of PAG and Src family kinases in T cells.
- DOI:10.1371/journal.pone.0046725
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Cao L;Ding Y;Hung N;Yu K;Ritz A;Raphael BJ;Salomon AR
- 通讯作者:Salomon AR
Quantitative Interactomics of Lck-TurboID in Living Human T Cells Unveils T Cell Receptor Stimulation-Induced Proximal Lck Interactors.
- DOI:10.1021/acs.jproteome.0c00616
- 发表时间:2021-01-01
- 期刊:
- 影响因子:4.4
- 作者:Chua XY;Aballo T;Elnemer W;Tran M;Salomon A
- 通讯作者:Salomon A
Targeted proteomics: Current status and future perspectives for quantification of food allergens.
- DOI:10.1016/j.jprot.2016.04.018
- 发表时间:2016-06-30
- 期刊:
- 影响因子:3.3
- 作者:Ahsan N;Rao RSP;Gruppuso PA;Ramratnam B;Salomon AR
- 通讯作者:Salomon AR
Ovalbumin Antigen-Specific Activation of Human T Cell Receptor Closely Resembles Soluble Antibody Stimulation as Revealed by BOOST Phosphotyrosine Proteomics.
- DOI:10.1021/acs.jproteome.1c00239
- 发表时间:2021-06-04
- 期刊:
- 影响因子:4.4
- 作者:Chua XY;Salomon A
- 通讯作者:Salomon A
Protein networks and activation of lymphocytes.
- DOI:10.1016/j.coi.2015.01.019
- 发表时间:2015-04
- 期刊:
- 影响因子:7
- 作者:Helou, Ynes A.;Salomon, Arthur R.
- 通讯作者:Salomon, Arthur R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR Robert SALOMON其他文献
ARTHUR Robert SALOMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR Robert SALOMON', 18)}}的其他基金
Phosphoproteomic Analysis of T Cell Activation Pathways
T 细胞激活途径的磷酸化蛋白质组学分析
- 批准号:
8468632 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Phosphoproteomic Analysis of T Cell Activation Pathways
T 细胞激活途径的磷酸化蛋白质组学分析
- 批准号:
8277233 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Phosphoproteomic Analysis of T Cell Activation Pathways
T 细胞激活途径的磷酸化蛋白质组学分析
- 批准号:
8079748 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Phosphoproteomic Analysis of T Cell Activation Pathways
T 细胞激活途径的磷酸化蛋白质组学分析
- 批准号:
7887159 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Phosphoproteomic Analysis of Feedback Networks in T cell signaling
T 细胞信号传导反馈网络的磷酸化蛋白质组学分析
- 批准号:
9915845 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Phosphoproteomic Analysis of T Cell Activation Pathways
T 细胞激活途径的磷酸化蛋白质组学分析
- 批准号:
8661694 - 财政年份:2010
- 资助金额:
$ 40.81万 - 项目类别:
Towards a Molecular Signature of Neutrophil Priming
中性粒细胞启动的分子特征
- 批准号:
7708311 - 财政年份:2009
- 资助金额:
$ 40.81万 - 项目类别:
HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF SIGNALING PATHWAYS
信号通路的高通量蛋白质组分析
- 批准号:
7959357 - 财政年份:2009
- 资助金额:
$ 40.81万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10522591 - 财政年份:2022
- 资助金额:
$ 40.81万 - 项目类别:
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10884052 - 财政年份:2022
- 资助金额:
$ 40.81万 - 项目类别:
Identification of novel tumor antigens binding to canine HSP70, and their application to tumor immunotherapy
与犬HSP70结合的新型肿瘤抗原的鉴定及其在肿瘤免疫治疗中的应用
- 批准号:
17K08108 - 财政年份:2017
- 资助金额:
$ 40.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7684654 - 财政年份:2008
- 资助金额:
$ 40.81万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
8131731 - 财政年份:2008
- 资助金额:
$ 40.81万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7499132 - 财政年份:2008
- 资助金额:
$ 40.81万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7920187 - 财政年份:2008
- 资助金额:
$ 40.81万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
7282042 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
6984696 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
7484257 - 财政年份:2005
- 资助金额:
$ 40.81万 - 项目类别:














{{item.name}}会员




